All Pharmaceutical industry articles – Page 11

View all stories with this category.

Business
Lilly and CureVac to collaborate on mRNA cancer vaccines

2017-11-06T12:34:00Z

Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
Business
GSK’s shingles vaccine gets thumbs up in North America

2017-11-02T09:01:00Z

Inoculation slated to be a blockbuster
Business
Judges overturn J&J talc cancer claims

2017-10-26T13:30:00Z

Two new rulings follow trend of reversing large jury-awarded damages as firm works through thousands of cases
Opinion
Rise of the biologics

2017-10-26T12:23:00Z

Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
Business
Drug formula change infuriates French thyroid patients

2017-10-24T10:01:00Z

Poor communication of changes to Merck KGaA’s levothyroxine has led to complaints of side effects
Business
Hurricane damage squeezes supply chains

2017-10-20T13:33:00Z

Industry and government working to minimise impact of shortages of olefin feedstocks and medical products
Business
Federal court quashes Allergan eye drop patents

2017-10-17T13:01:00Z

Ruling negates company’s deal with Mohawk tribe to avoid patent board review
$C:\Users\traceys\Downloads$
Business
US to invest $160m in cancer partnership

2017-10-17T11:44:00Z

Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
Business
Call for overhaul of EU rules on GMO clinical trial

2017-10-11T16:08:00Z

Rules designed around genetically modified plants crops are holding back new cell and gene-based medicines
Business
US government urged to exercise drug patent rights

2017-10-06T15:18:00Z

Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
Business
Long road to recovery for Puerto Rico pharmaceuticals

2017-10-06T14:13:00Z

As inhabitants begin to rebuild their lives after the devastation of hurricane Maria, the island’s drug manufacturers are recovering slowly
Business
US state passes law blocking generic drug price-gouging

2017-10-05T14:28:00Z

Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
Business
Amgen partners to launch biosimilars in China

2017-09-29T12:07:00Z

US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
Business
US probes opioid manufacturers

2017-09-28T15:19:00Z

Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
Feature
Photoredox: charge of the LED brigade

2017-09-20T14:00:00Z

Forget fluorescent light bulbs, photochemistry has become a lot more sophisticated
Business
Teva to sell off women’s health businesses for $1.4bn

2017-09-20T13:24:00Z

Deals continue Teva’s bid to get rid of non-core businesses and raise cash to service its debts
Business
Allergan sidesteps patent review with tribal deal

2017-09-19T14:08:00Z

Native Americans agree to use sovereign immunity to protect intellectual property from double challenge
Business
Alexion axes 20% of its global workforce

2017-09-18T15:36:00Z

600 jobs lost amid restructure as firm moves to Boston life sciences hub
Opinion
An opportunity ignored

2017-09-15T12:00:00Z

Dismissing ideas that were ‘not invented here’ is like walking past a $100 bill
Business
Teva sells off contraceptive device in $1.1bn deal

2017-09-14T11:31:00Z

CooperSurgical to acquire Paragard as Teva seeks to offload assets